In this study, we demonstrated for the first time the DMF potential for treatment of migraine, modulating the inflammatory state and strengthening the antioxidant Nrf-2 transcriptional pathway, as confirmed by the in vitro study. This evidence concerns the gene NFE2L2 and migraine disorder.